Friday, January 18, 2019 1:50:54 PM
- if we look back at all the challenges that OWCP has had and still OWCP has managed to get their products tested in some of the most respected hospitals in Israel,...
- and kept at doing the necessary work to receive patents
- and hired on and joined work with some top level researchers and scientists that hold patents and brought public companies forward with substantial buyouts.
so we don't really know that there are no II's (institutional investors).
my WAG is if OWCP approached II's with their (OWCP's scientific and research) data and it was seriously reviewed for its potential as the CBD market opens,...II's would have invested in this ground floor opportunity and just wait it out.
granted they as institutional investors would have privy information from OWCP, the company, that we, the retail investor, would not. but that is how it works. angel investors and other institutions get that privilege with an NDA signed.
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM